Bitter CRISPR patent war intensifies – Nature.com
Nature.com |
Bitter CRISPR patent war intensifies
Nature.com At stake are intellectual-property rights to the use of CRISPR–Cas9 gene-editing tools in eukaryotes, organisms such as plants and animals. This would include applications of the technique to treat human genetic diseases — an approach that has … Broad Institute Responds to UC Berkeley Appeal of CRISPR-Cas9 Patent Interference Decision |
